QBie™ Spotlight: Kane Biotech Inc. (OTCQB: KNBIF)

QBie™ Spotlight joins Mark Ahrens-Townsend, President & CEO, of Kane Biotech Inc. (OTCQB: KNBIF), to discuss one of the OTCQB’s newest additions. KNBIF joined the OTCQB on February 1, 2018. What does Kane Biotech do? Mark Ahrens-Townsend (President & CEO- OTCQB: KNBIF): “Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products
Read more